IOVA

IOVANCE BIOTHERAPEUTICS, INC.

Insider activity for last month from 08/04 to 09/04. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.

Latest filingSep 03, 2026Most recent Form 4
Total buying$00 buys
Total selling$00 sells
Net open-market+$03 insiders
Open-market mix
Buy vs sell distribution by transaction count
0 transactions

Insider activity report

Monthly open-market purchase and sale counts
Buys Sells
530-3-5transactionsAugSep

Transaction codes

By Form 4 transaction code in selected period
9transactions
  • M · Option exercise · dominant6 · 67%
  • F · Tax withholding3 · 33%

Activity by reported role

A joint filing can contribute to multiple roles
12transactions
  • COO · dominant3 · 25%
  • CRO3 · 25%
  • GC3 · 25%
  • IC3 · 25%

Distinct insiders active

Reporting-owner CIKs by month · peak Sep 2026 (3)
Aug 2026Sep 2026
3distinct insiders in 2 months

Reported Holdings After

Separated by insider, security, and ownership type
Bilinsky IgorCommon Stock · Direct
142.7k138.2kSep 01, 2026 · 138,237 shares owned afterSep 01, 2026 · 142,709 shares owned afterSep 01, 2026Sep 01, 2026
142,709Sep 01, 2026
Puri Raj K.Common Stock · Direct
253.6k251.1kSep 01, 2026 · 251,076 shares owned afterSep 01, 2026 · 253,584 shares owned afterSep 01, 2026Sep 01, 2026
253,584Sep 01, 2026
Vogt Frederick GCommon Stock · Direct
604.2k586.5kSep 01, 2026 · 604,161 shares owned afterSep 01, 2026 · 586,459 shares owned afterSep 01, 2026Sep 01, 2026
586,459Sep 01, 2026
Bilinsky IgorRestricted Stock Units · Direct
17.6k17.6kSep 01, 2026 · 17,580 shares owned afterSep 01, 2026Sep 01, 2026
17,580Sep 01, 2026
Puri Raj K.Restricted Stock Units · Direct
10.9k10.9kSep 01, 2026 · 10,939 shares owned afterSep 01, 2026Sep 01, 2026
10,939Sep 01, 2026
Vogt Frederick GRestricted Stock Units · Direct
83.3k83.3kSep 01, 2026 · 83,338 shares owned afterSep 01, 2026Sep 01, 2026
83,338Sep 01, 2026

These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.

Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells red
0 active days
Aug 04Sep 04
LessMore

Filing detail checks

Secondary metrics for the selected period
Largest buy-
Largest sale-
10b5-1 detected0
Amended rows0

Filing-only signals

Deterministic matches in the selected period

No filing-only signal badges matched this period.

IOVA transaction history

Filters apply within this company and selected period by default
Reset
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date

No transactions match your filters

Once the backend ingests and parses SEC filings, they will appear here. Try removing a filter or picking a wider date range.

IOVANCE BIOTHERAPEUTICS, INC. Insider Activity FAQ

SEC Form 4 context

Who recently reported transactions at IOVANCE BIOTHERAPEUTICS, INC.?

Vogt Frederick G, Puri Raj K., BILINSKY IGOR.

When was the latest reported open-market purchase?

No code-P purchase is available for this period.

When was the latest reported open-market sale?

No code-S sale is available for this period.

What is the recent purchase and sale balance?

No code-P purchases or code-S sales were reported in the selected period.

Where can I see the original SEC filing?

Every transaction row and latest-activity fact links to its original SEC filing.

What do these Form 4 transaction codes mean?

P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.